(Q47669564)

4 February 2018

title

Alzheimer's disease: epidemiology. (English)

1 reference

4 February 2018

1 reference

1 reference

Richard Mayeux

1

1 reference

4 February 2018

publication date

1 January 2008

1 reference

4 February 2018

Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn

published in

1 reference

4 February 2018

volume

89

1 reference

4 February 2018

page(s)

195-205

1 reference

4 February 2018

Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Incidence of very mild to severe dementia and Alzheimer's disease in Denmark: the Odense Study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Depression and the risk of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

The genetic epidemiology of neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Evidence for genetic linkage of Alzheimer's disease to chromosome 10q

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Alpha-2 macroglobulin is genetically associated with Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Results of a high-resolution genome screen of 437 Alzheimer's disease families

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Developmental and vascular risk factors for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Epidemiology of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Prevalence of Alzheimer's disease and other dementias in rural India: the Indo-US study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Incidence of Alzheimer's disease in a rural community in India: the Indo-US study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Sources of variability in prevalence rates of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Does participation in leisure activities lead to reduced risk of Alzheimer's disease? A prospective study of Swedish twins

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Depressive symptoms, sex, and risk for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

The number of trait loci in late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Smoking and dementia in male British doctors: prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Neuroinflammatory perspectives on the two faces of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Fine mapping of the -T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Estimated prevalence of Alzheimer's disease in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Prevalence of Alzheimer's disease and other dementing disorders: Assiut-Upper Egypt study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Global prevalence of dementia: a Delphi consensus study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Participation in novelty-seeking leisure activities and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Alzheimer Disease and Mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Head injury and the risk of AD in the MIRAGE study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

An 18-year follow-up of overweight and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

A genome-wide linkage analysis of dementia in the Amish

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Mortality with dementia: results from a French prospective community-based cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

High carbohydrate diets and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Genome-wide association studies for common diseases and complex traits

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Incidence and course of dementia in people with Down's syndrome: findings from a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Stroke and the risk of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Rate of cognitive decline and mortality in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Biomarkers of Alzheimer disease in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Head injury and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Molecular genetics of late-onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Editorial: The prevalence and malignancy of Alzheimer disease. A major killer

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

alpha2-macroglobulin in late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Gender differences in predictors of mortality in nursing home residents with AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Midlife blood pressure and dementia: the Honolulu-Asia aging study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Physical activity and risk of cognitive impairment and dementia in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Risk of dementia and alcohol and wine consumption: a review of recent results.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Estrogen and brain: synthesis, function and diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Longitudinal follow-up of depressive symptoms among normal versus cognitively impaired elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Incidence of dementia in a rural community in Spain: the Girona cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Cardiovascular risk factors and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Antioxidant vitamin intake and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Hyperinsulinemia and risk of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Alcohol intake and risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Aggregation of vascular risk factors and risk of incident Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Biological markers of Alzheimer's disease and mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Cognitive decline and literacy among ethnically diverse elders.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Head trauma and risk of dementia and Alzheimer's disease: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Association of polymorphisms in the Angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

The influence of smoking on the risk of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

High total cholesterol levels in late life associated with a reduced risk of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Incidence of dementia in a representative British sample

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Selective inhibition of Abeta42 production by NSAID R-enantiomers

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Educational attainment and socioeconomic status of patients with autopsy-confirmed Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Susceptibility locus for Alzheimer's disease on chromosome 10.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Full genome screen for Alzheimer disease: Stage II analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Traumatic brain injury and time to onset of Alzheimer's disease: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Epidemiology of dementia in Nigeria: results from the Indianapolis-Ibadan study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Mortality in elderly Canadians with and without dementia: a 5-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Association of diabetes mellitus and dementia: the Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Vascular risk and genetics of sporadic late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Lipid metabolism in cognitive decline and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Molecular genetics of Alzheimer’s disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Incidence of dementia and cognitive decline in over-75s in Cambridge: overview of cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Identification of Novel Genes in Late-Onset Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Study of plasma antioxidant status in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

The age-dependent relation of blood pressure to cognitive function and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Incidence and etiology of dementia in a large elderly Italian population

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

The prevalence of vascular dementia in Europe: facts and fragments from 1980-1990 studies. EURODEM-Prevalence Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Incidence of dementia: does gender make a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Influence of leisure activity on the incidence of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Mediterranean diet and risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Alzheimer's disease after remote head injury: an incidence study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Specificity of the fivefold increase in AD in mothers of adults with Down syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Further evidence linking late-onset Alzheimer disease with chromosome 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

No genetic association between the LRP receptor and sporadic or late-onset familial Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

The link between cholesterol and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Hypertension, hypertension-clustering factors and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Micronutrients and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Influence of education and occupation on the incidence of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Molecular genetics of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Molecular biology and genetics of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Plasma levels of amyloid beta proteins did not differ between subjects taking statins and those not taking statins

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Insulin increases CSF Abeta42 levels in normal older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

A reevaluation of the duration of survival after the onset of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Genetic studies on chromosome 12 in late-onset Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

A preliminary analysis of incidence of dementia in Shanghai, China

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2901218-3

7 January 2021

10.1016/S0072-9752(07)01218-3

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

18631744

1 reference

4 February 2018